#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Osteosarcoma metastatic Dent's disease Bulbospinal muscular atrophy congenital Malignant oligodendroglioma Biotinidase deficiency IPEX syndrome Spinal cord injury cervical Osteochondrodysplasia Inborn error of metabolism Leiomyosarcoma metastatic Pemphigus Arteriosclerosis Polyneuropathy Familial hypertriglyceridaemia Small cell lung cancer limited stage More trials…

    Learn about Rare Diseases

    Testicular leiomyosarcoma – Basic Information Primary biliary cholangitis Arterial tortuosity syndrome – Diagnostics Alternating hemiplegia of childhood – Diagnostics Retinoblastoma – Treatment Fragile X syndrome – Treatment Angelman’s syndrome – Treatment Hereditary angioedema with C1 esterase inhibitor deficiency – Treatment Prolymphocytic leukaemia – Treatment Shprintzen-Goldberg syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Absk021 Hydrochloride Hydrate AZD0022 Bimatoprost CYCLIZINE HYDROCHLORIDE Tirbanibulin Xanthum Gum SAR444336 Doxecitine Gemlapodect Valine Tiratricol OMTX705 Azithromycin Pristinamycin Avibactam Sodium Gremubamab Tropicamide Zinc Acetate Dihydrate Purified Egg Phospholipids Tiragolumab More therapies…

    Learn about Your Condition

    Varices oesophageal Haemorrhage intracranial Cholestatic pruritus Langerhans cell sarcoma Burning mouth syndrome Indolent systemic mastocytosis Acute hepatic failure Atrophic vulvovaginitis Kaposi's sarcoma Ovarian cancer metastatic Thrombosis prophylaxis Pneumonia Mantle cell lymphoma stage IV Parkinson's disease Oesophagogastroscopy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Axial spondyloarthritis

  • Study of Janus kinase inhibitor dose reduction in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis who have achieved low disease activity

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    • Rheumatic disorder
    • Rheumatoid arthritis
    Investigated Drugs:
    • Filgotinib
    • Baricitinib
    • Tofacitinib
    The Netherlands

  • Study on the Effects of Upadacitinib for Patients with Active Psoriatic Arthritis and Axial Spondyloarthritis

    Recruiting

    3 1
    Investigated Diseases:
    • Axial spondyloarthritis
    • Psoriatic arthropathy
    Investigated Drugs:
    • Upadacitinib
    Belgium Poland

  • Study of 18F-AlF-FAPI-74 PET/CT imaging compared to standard 18F-FDG PET/CT in patients with fever of unknown origin, IgG4-related disease, and axial spondyloarthritis

    Recruiting

    4 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    • Immunoglobulin G4 related disease
    • Pyrexia
    Investigated Drugs:
    • [Al[18F]F]Fapi-74
    Belgium

  • Study on the Effects of Sonelokimab in Patients with Active Psoriatic Arthritis or Axial Spondyloarthritis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    • Psoriatic arthropathy
    Investigated Drugs:
    • Sonelokimab
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    Germany

  • Study Comparing Infliximab and NSAID Drug Combination for Patients with Axial Spondyloarthritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    Investigated Drugs:
    • Diclofenac Diethylamine
    • Etoricoxib
    • Ibuprofen Lysine
    Germany

  • Study on Fecal Microbiota Transplantation for Patients with Axial Spondyloarthritis Resistant to Conventional Treatment

    Recruiting

    2 1
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    France
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!